InVision develops AI to streamline the interpretation of heart ultrasounds and identify undiagnosed disease.
Location: United States, California, Los Angeles
Investors 2
| Date | Name | Website |
| 28.08.2022 | Y Combinat... | ycombinato... |
| - | Carnrite V... | carnriteve... |
Mentions in press and media 1
| Date | Title | Description |
| 05.08.2026 | Medicare Establishes Dedicated Reimbursement for InVision's AI Detection of Cardiac Amyloidosis | InVision Medical Technology CMS finalizes a New Technology Add-on Payment (NTAP) under code XEZZXLC, effective October 1, 2026, completing a Medicare payment pathway for InVision. Cardiac amyloidosis often hides in plain sight on echocardio... |